2,849,402 Shares in Whitehawk Therapeutics, Inc. $WHWK Purchased by Avoro Capital Advisors LLC

Core Insights - Avoro Capital Advisors LLC acquired 2,849,402 shares of Whitehawk Therapeutics, valued at approximately $5,414,000, making it the 29th largest holding in their portfolio [2] - Institutional investors and hedge funds collectively own 52.08% of Whitehawk Therapeutics, with notable new stakes from Dimensional Fund Advisors LP ($84,000), Peapod Lane Capital LLC ($577,000), and Vanguard Group Inc. ($2,552,000) [3] Stock Performance - Whitehawk Therapeutics shares opened at $3.91, with a market cap of $184.28 million, a price-to-earnings ratio of 8.32, and a beta of 0.51 [4] - The stock has a fifty-day moving average price of $3.02 and a 200-day moving average price of $2.48, with a fifty-two week low of $1.39 and a high of $4.48 [4] Earnings Results - The company reported earnings per share (EPS) of ($0.34), exceeding the consensus estimate of ($0.55) by $0.21 [5] Analyst Ratings - Weiss Ratings reaffirmed a "sell (d-)" rating, while JonesTrading initiated coverage with a "buy" rating and a target price of $7.00 [6] - Oppenheimer issued an "outperform" rating with a target price of $6.00, resulting in a consensus rating of "Hold" and an average price target of $6.50 [6]